QuatRx Pharmaceuticals of Ann Arbor, MI, has filed for an IPO designed to raise $86.2 million. QuatRx was founded in 2000 and has been developing drugs for cardiovascular, metabolic and endocrine disorders. The underwriters of the offering will be Banc of America Securities, as sole book-running manager, SG Cowen & Co., as co-lead manager, and Lazard Capital Markets and Pacific Growth Equities as co-managers.
- read this release for more information